MPR

FDA Greenlights Caplyta for Adjunctive Use in MDD

The Food and Drug Administration (FDA) has approved Caplyta ® (lumateperone) as an adjunctive therapy with antidepressants for the treatment of major depressive disorder (MDD) in adults.
MPR

Linzess Approval Expanded to Include Pediatric IBS-C

The Food and Drug Administration (FDA) has approved Linzess ® (linaclotide) for the treatment of irritable bowel syndrome with constipation (IBS-C) in patients 7 years of age and older. Previously, ...
MPR

Serial Ketamine Infusions No Aid for Inpatient Major Depressive Episodes

HealthDay News — Serial adjunctive ketamine infusions are not more effective than serial midazolam infusions in reducing depressive symptoms in patients receiving inpatient psychiatric care for a ...
MPR

Maldives Becomes First Nation to Ban Smoking for an Entire Generation

HealthDay News — The Maldives has become the first country in the world to ban tobacco use for an entire generation, after a new law took effect Saturday.
MPR

Could Pig Kidneys End the Transplant Shortage? First US Trial Begins

HealthDay News — A first-of-its-kind clinical trial is beginning in the US to see if pig kidneys could help save the lives of people waiting for a human organ transplant.